Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus
Go back to Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 73.46 +0.93 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.53 | 52 Week High | $39.41 | |||
| Open | $73.06 | 52 Week Low | $25.98 | |||
| Day High | $73.80 | P/E | 103.46 | |||
| Day Low | $72.86 | EPS | $0.71 | |||
| Volume | 162,582 | |||||
